614 related articles for article (PubMed ID: 18162536)
1. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis.
Gitler AD; Bevis BJ; Shorter J; Strathearn KE; Hamamichi S; Su LJ; Caldwell KA; Caldwell GA; Rochet JC; McCaffery JM; Barlowe C; Lindquist S
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):145-50. PubMed ID: 18162536
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae.
Soper JH; Roy S; Stieber A; Lee E; Wilson RB; Trojanowski JQ; Burd CG; Lee VM
Mol Biol Cell; 2008 Mar; 19(3):1093-103. PubMed ID: 18172022
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.
Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; Cao S; Caldwell KA; Caldwell GA; Marsischky G; Kolodner RD; Labaer J; Rochet JC; Bonini NM; Lindquist S
Science; 2006 Jul; 313(5785):324-8. PubMed ID: 16794039
[TBL] [Abstract][Full Text] [Related]
4. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.
Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S
Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714
[TBL] [Abstract][Full Text] [Related]
5. alpha-synuclein and Parkinson's disease: the first roadblock.
Chua CE; Tang BL
J Cell Mol Med; 2006; 10(4):837-46. PubMed ID: 17125588
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs.
Thayanidhi N; Helm JR; Nycz DC; Bentley M; Liang Y; Hay JC
Mol Biol Cell; 2010 Jun; 21(11):1850-63. PubMed ID: 20392839
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional interactions of alpha-synuclein with Rab3a.
Lv G; Ko MS; Das T; Eliezer D
J Biol Chem; 2022 Sep; 298(9):102239. PubMed ID: 35809645
[TBL] [Abstract][Full Text] [Related]
8. Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease.
Lashuel HA; Hirling H
ACS Chem Biol; 2006 Aug; 1(7):420-4. PubMed ID: 17168518
[TBL] [Abstract][Full Text] [Related]
9. Ypt1p is essential for retrograde Golgi-ER transport and for Golgi maintenance in S. cerevisiae.
Kamena F; Diefenbacher M; Kilchert C; Schwarz H; Spang A
J Cell Sci; 2008 Apr; 121(Pt 8):1293-302. PubMed ID: 18388317
[TBL] [Abstract][Full Text] [Related]
10. Rab proteins of the endoplasmic reticulum: functions and interactors.
Ortiz Sandoval C; Simmen T
Biochem Soc Trans; 2012 Dec; 40(6):1426-32. PubMed ID: 23176493
[TBL] [Abstract][Full Text] [Related]
11. Rab6 regulates both ZW10/RINT-1 and conserved oligomeric Golgi complex-dependent Golgi trafficking and homeostasis.
Sun Y; Shestakova A; Hunt L; Sehgal S; Lupashin V; Storrie B
Mol Biol Cell; 2007 Oct; 18(10):4129-42. PubMed ID: 17699596
[TBL] [Abstract][Full Text] [Related]
12. Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis.
Soper JH; Kehm V; Burd CG; Bankaitis VA; Lee VM
J Mol Neurosci; 2011 Mar; 43(3):391-405. PubMed ID: 20890676
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease.
Wang S; Zhang S; Liou LC; Ren Q; Zhang Z; Caldwell GA; Caldwell KA; Witt SN
Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E3976-85. PubMed ID: 25201965
[TBL] [Abstract][Full Text] [Related]
14. Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
Wang S; Zhang S; Xu C; Barron A; Galiano F; Patel D; Lee YJ; Caldwell GA; Caldwell KA; Witt SN
PLoS One; 2016; 11(10):e0164465. PubMed ID: 27736935
[TBL] [Abstract][Full Text] [Related]
15. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
16. Initial docking of ER-derived vesicles requires Uso1p and Ypt1p but is independent of SNARE proteins.
Cao X; Ballew N; Barlowe C
EMBO J; 1998 Apr; 17(8):2156-65. PubMed ID: 9545229
[TBL] [Abstract][Full Text] [Related]
17. The Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family alters alpha synuclein (α-syn) oligomerization and secretion.
von Einem B; Eschbach J; Kiechle M; Wahler A; Thal DR; McLean PJ; Weishaupt JH; Ludolph AC; von Arnim CAF; Danzer KM
Aging (Albany NY); 2017 Jul; 9(7):1677-1697. PubMed ID: 28722658
[TBL] [Abstract][Full Text] [Related]
18. Rewiring a Rab regulatory network reveals a possible inhibitory role for the vesicle tether, Uso1.
Yuan H; Davis S; Ferro-Novick S; Novick P
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8637-E8645. PubMed ID: 28973856
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.
Mazzulli JR; Zunke F; Isacson O; Studer L; Krainc D
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1931-6. PubMed ID: 26839413
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.
Gitler AD; Chesi A; Geddie ML; Strathearn KE; Hamamichi S; Hill KJ; Caldwell KA; Caldwell GA; Cooper AA; Rochet JC; Lindquist S
Nat Genet; 2009 Mar; 41(3):308-15. PubMed ID: 19182805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
